Severity of Illness Index
"Severity of Illness Index" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
| Descriptor ID |
D012720
|
| MeSH Number(s) |
E05.318.308.980.438.475.456.500 N05.715.360.300.800.438.375.364.500 N06.850.520.308.980.438.475.364.500
|
| Concept/Terms |
Severity of Illness Index- Severity of Illness Index
- Illness Index Severities
- Illness Index Severity
- Index Severities, Illness
- Index Severity, Illness
|
Below are MeSH descriptors whose meaning is more general than "Severity of Illness Index".
Below are MeSH descriptors whose meaning is more specific than "Severity of Illness Index".
This graph shows the total number of publications written about "Severity of Illness Index" by people in this website by year, and whether "Severity of Illness Index" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 8 | 10 |
| 1997 | 2 | 12 | 14 |
| 1998 | 0 | 8 | 8 |
| 1999 | 1 | 15 | 16 |
| 2000 | 1 | 18 | 19 |
| 2001 | 2 | 22 | 24 |
| 2002 | 1 | 35 | 36 |
| 2003 | 5 | 39 | 44 |
| 2004 | 5 | 33 | 38 |
| 2005 | 3 | 38 | 41 |
| 2006 | 1 | 57 | 58 |
| 2007 | 3 | 59 | 62 |
| 2008 | 6 | 54 | 60 |
| 2009 | 3 | 76 | 79 |
| 2010 | 6 | 58 | 64 |
| 2011 | 7 | 65 | 72 |
| 2012 | 6 | 54 | 60 |
| 2013 | 9 | 65 | 74 |
| 2014 | 9 | 54 | 63 |
| 2015 | 11 | 71 | 82 |
| 2016 | 9 | 77 | 86 |
| 2017 | 8 | 76 | 84 |
| 2018 | 13 | 77 | 90 |
| 2019 | 8 | 84 | 92 |
| 2020 | 9 | 82 | 91 |
| 2021 | 4 | 65 | 69 |
| 2022 | 0 | 18 | 18 |
| 2023 | 2 | 19 | 21 |
| 2024 | 13 | 56 | 69 |
| 2025 | 3 | 55 | 58 |
| 2026 | 3 | 36 | 39 |
To return to the timeline,
click here.
Below are the most recent publications written about "Severity of Illness Index" by people in Profiles.
-
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial. Inflamm Bowel Dis. 2026 Sep 01; 32(9):1669-1682.
-
Nongenetic Factors Associated With Onset and Severity of Hereditary Ataxia. Neurology. 2026 Sep 08; 107(5):e218378.
-
Fluid balance and acute lung injury in children and young adults receiving continuous renal replacement therapy: a report from the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK). Eur J Pediatr. 2026 Aug 04; 185(8).
-
Does Quality of Life and Symptom Severity Correlate with Celiac Disease Serology in Adolescents? Dig Dis Sci. 2026 Nov; 71(11):5691-5698.
-
Risk profile and prognostic implications of premature advanced coronary atherosclerotic disease among young to early middle-aged adults: the coronary artery calcium consortium. Eur J Prev Cardiol. 2026 Jul 14; 33(9):1621-1628.
-
Impact of preoperative depression severity and antidepressant medication use on perioperative outcomes and long-term weight loss following primary bariatric surgery. Surg Endosc. 2026 Aug; 40(8):7133-7142.
-
Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial. J Crohns Colitis. 2026 Jul 07; 20(7).
-
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial. JAMA Dermatol. 2026 07 01; 162(7):709-719.
-
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative Colitis. United European Gastroenterol J. 2026 Jul; 14(6):e70227.
-
Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19. Crit Care Explor. 2026 Jul 01; 8(7):e1405.